Patent · US Active

Treatment and prevention of Alzheimer's disease (AD)

US11857568B2 · kind B2 · utility

0Cited by

4References

19Claims

0Family size

Assignee

Advantage Therapeutics, Inc. · US

Inventors

Markus Mandler · Wien, AT
Achim Schneeberger · Fort Lauderdale, US
Wolfgang Zauner · Wien, AT
Arne Von Bonin · Hohen Neuendorf, DE
Frank Mattner · Wien, AT
Walter Schmidt · Wien, AT

Key dates

Filing date	Jul 8, 2021
Grant date	Jan 2, 2024
Priority date	—
Expiry date	Nov 4, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention discloses an aluminium salt for use in the treatment and prevention of dementias associated with β-amyloid deposition, preferably AD.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.